Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Hypertrophic cardiomyopathy

New Blood Test Revolutionizes Detection of Fatal Heart Condition in Children

Recent advancements in technology have led to a groundbreaking development in preventing sudden cardiac deaths in children. A new blood test can now identify Hypertrophic Cardiomyopathy and assess the risk of fatality, offering a more accessible and potentially life-saving diagnostic tool. This innovation marks a significant step forward in pediatric healthcare, allowing healthcare professionals to proactively manage cardiac conditions in children and safeguard their well-being.

Understanding Hypertrophic Cardiomyopathy: A Common Genetic Heart Condition

Learn about hypertrophic cardiomyopathy (HCM), a common genetic heart condition characterized by thickening of the heart muscle. Despite being potentially silent, HCM can lead to symptoms like increased heart rhythm issues and sudden cardiac death. Recognizing family history and genetic factors is crucial for timely diagnosis and treatment.

Cytokinetics, Inc. Retains Favorable Outlook with New Heart Disease Study Data

Cytokinetics, Inc. showcases new data from ongoing heart disease study, reporting significant reductions in left ventricular outflow tract gradient and positive outcomes in NT-proBNP, cardiac structure, and function. Mizuho reiterates Buy rating with a steady price target of $99.00.

Groundbreaking Discovery in Cardiomyopathy Research

Scientists at The Hospital for Sick Children (SickKids) have made a groundbreaking discovery in the study of cardiomyopathy, an inherited heart condition that affects a significant portion of the population. The research, published in eBioMedicine, a part of The Lancet Discovery Science, utilized whole genome sequencing to investigate tandem repeat expansions (TREs) in heart conditions, providing valuable insights into early detection and potential precision therapies for cardiomyopathy.